Is Tianjin Hongri Pharmaceutical a state-owned enterprise?

Tianjin Hongri Pharmaceutical is a state-owned enterprise. Tianjin Hongri Pharmaceutical Co., Ltd., founded in 1996, is the first batch of enterprises listed on the Growth Enterprise Market in China. Up to now, it has developed into a high-tech medical and health industrial cluster integrating investment and financing, production, R&D and sales, spanning many fields such as finished drugs, traditional Chinese medicine industrial clusters, pharmaceutical excipients and raw materials, medical devices and so on. , more than 60 companies, more than 6000 employees. In recent years, the company has won many honors such as national high-tech enterprises and national technological innovation demonstration enterprises, and has become one of the top 100 pharmaceutical industries in China. In 20 19, the main business income was 5 billion yuan, the total assets were 8.454 billion yuan, and the tax payment was 690 million yuan. Scientific and technological innovation and industrialization of achievements are the source power for the continuous development of Hongri Pharmaceutical. Hongri Pharmaceutical Co., Ltd. relies on two established national technical platforms, namely the National Enterprise Technology Center and the National and Local Joint Engineering Research Center for Key Technologies of Chinese Medicine Formula Granules, and cooperates with famous academicians such as Zhong Nanshan and Zhang Boli to continuously carry out innovative research on key technologies such as anti-tumor, Xuebijing treatment in COVID-19 and secondary development of Chinese patent medicines.